Connect with Us:

PARTICIPANT LIST Ole Kristian Aars, M.A., CEPI/NIPH

Teresa Abraham, Ph.D., SMI Inc

Melton Affrime, PharmD Senior Vice President Translational Medicine Wcct Global

Cyrus Agarabi, Ph.D., FDA/CDER

Eddy Agbo, , DVM PhD Chairman & CEO Fyodor Biotechnologies Inc.

David Aglow, B.S., HHS/ASPR/BARDA

Heidi Agostini, Ph.D., Director Government Programs Medimmune

Akhil Agrawal, B.A., American Medical Depot

Ronald Aimes, Ph.D., Sr. Advisor Mapp Biopharmaceutical Inc.

Jeffery Alexander, Ph.D., VP Research Paxvax

Masarrat Ali, Ph.D., CEO/Chief Scientific Officer Alpha Diagnostic Intl Inc

Lynn Allen‐Hoffman, Ph.D., Senior Vice President Regenerative Medicine Stratatech A Mallinckrodt Company

Richard Alm, Ph.D., VP BiologyMacrolide Pharmaceuticals

Emma Alterman, B.A., Abl Inc.

Jennifer Alton, MPP VP Government Affairs Bavarian Nordic

Jose Alvelo, M.S., Vector Consulting Group LLC

M Javad Aman, Ph.D., President and CSO Integrated Biotherapeutics

Michael Amante, , MBA Principal Continuum LLC

Michael Angelastro, B.S., Deputy Director BARDA / MFE HHS/ASPR/BARDA

David Angulo, M.D., Chief Medical Officer Scynexis

Macaluso Anthony, Ph.D., Chief Technical Officer Medical Countermeasure Systems HHS/ASPR/BARDA

Mark Armitage, Ph.D., Johnson & Johnson

Kimberly Armstrong, Ph.D., Health Scientist HHS/ASPR/BARDA

Frank Arnold, Ph.D., HHS/ASPR/BARDA

Andrew Arrage, M.S., MBA ABL Inc.

RONALD ATKINSON, B.S., MBA Project Manager Emergent Biosolutions

Gregory Auner, Ph.D., Medical Engineering Partners

Brett Baker, , D.C. President and CSO Microbion Corporation

Justin Baker, Ph.D., Viscus Biologics

Shenda Baker, Ph.D., President and COO Synedgen

Robert Balog, Ph.D., SRI International

Steven Baranowitz, M.D., Epitek Inc.

Todd Barnett, RN MBA Director of Government and Strategic Accounts Earlysense Inc.

Julio Barrera‐Oro, Ph.D., Health Scientist HHS/ASPR/BARDA

Elizabeth Barrows, M.S., Independent Consultant

Lee Barsky, M.A., VP Clinical Operations WCCT

1

  

  

           

               

               

             

             

          

       

  

             

        

       

       

       

    

         

       

  

       

              

              

           

                    

  

       

                 

       

                

            

    

         

             

                     

            

            

          

                

          

      

            

      

            

    

            

       

          

          

          

           

                

            

  

              

          

            

  

Bill Basinger, M.S., CEO Countervail Corporation

Mansour Bassiri, Ph.D., President & CEO Bioxiness Pharmaceuticals

Stephen Beaulieu, M.S.P.H., Principal Scientist Applied Research Associates

Elizabeth Becker, , MPA Embassy Of Denmark

Daniel Bednárik, Ph.D., Executive Consultant Microbion Corporation

Martin Beliveau, Ph.D., Director Certara

Thomas Bell, Ph.D., Cytosorbents

Khadija Ben Aissa, Ph.D., Senior Scientist Program Management Support Cubrc Inc.

Brandi Benford, M.S., MCS

Joffrey Benford, MBA HHS/ASPR/AMCG

JP Benya, MBA Assembly Biosciences

Francesco Berlanda Scorza, Ph.D., Path

Brooke Bernold, M.S., HHS/OS/ASPR/AMCG

Diane Berry, Ph.D., Sarepta

Elizabeth Berry, M.A., Chenega Healthcare Services LLC

John Bigger, Ph.D., Senior Project Leader Southern Research

Sandra Bihary‐Waltz, M.S., DBA(c) Regulatory Specialist HHS/ASPR/BARDA

John Billington, , JD MPH Director U.S. Public Policy Vaccines GSK

Pamuk Bilsel, Ph.D., Flugen

Chad Black, Ph.D., Walter Reed Army Institute Of Research

Mark Blaskovich, Ph.D., Community For Open Antimicrobial Drug Discovery U Of Queensland

John Bogdan, Ph.D., Program Officer NIH/NIAID

JenniferBolognese,M.S. M.A. Proposal Manager & Technical Writer Westat

Wendy Boone, M.P.H., Director Clinical Operations Clinicalrm

Lizbet Boroughs, M.S.P.H., Associate Director of Federal Relations Association Of American Universities

David Boucher, Ph.D., Health Scientist HHS/ASPR/BARDA

Mark Bowen, B.S., Director Government Relations Univ Of Nebr Medical Center

Maria Braga, Ph.D., DDS. Ph Professor of Anatomy Physiology and Genetics Uniformed Services University Of The Health Sciences

Robert Brakaj, , MBA Director Business Development CCS Associates Inc.

Amanda Bright, , Doctor of Post‐Doctoral Fellow Novartis Pharmaceuticals Corporation

Rick Bright, Ph.D., Divison Director HHS/ASPR/BARDA

Ric Brock, B.S., Engagement Director Humphreys & Associates Inc

Brenda Brooks, M.A., Program Analyst US Food And Drug Administration

Trevor Brown, Ph.D., Sr. Scientist MCS‐DX

Lisa Brown, M.P.H., The National Academies Of Sciences Engineering And Medicine

Lisa Brown, B.A., HHS/ASPR/BARDA

Michelle Brusatori, Ph.D., Senior Scientist Medical Engineering Partners

Lucinda Buhse, Ph.D., Director FDA

Sandra Butler, M.D., Technical Resources International Inc.

2

  

  

           

  

       

       

        

       

    

           

      

        

        

                

          

          

       

  

              

                

       

  

             

 

           

       

          

               

        

        

       

        

       

    

       

  

               

       

  

           

                

       

                 

    

           

  

             

    

               

                 

       

  

       

       

      

        

                  

       

            

                  

       

  

                

 

Patrick Byrne, M.S., Logistics Management Specialist HHS/ASPR/BARDA

Craig Calson, M.S., HHS/ASPR/OPP

Bernard Cambou, Ph.D., Chief Business Officer Targazyme Inc.

Anthony Cann, Ph.D., Scibac Inc

Norma Cantu, M.S., Sr. Research Scientist Southwest Research Institute

Melissa Carr, , J.D. President Dimer LLC Dba Germfalcon

Nathalie Casado, M.S., Director of Business Development Kestrel Corporation

Michael Cavanaugh, , Masters Cl VP Business Development Kbi Biopharma Inc.

Ashley Cecere, M.S., HHS/ASPR/BARDA

Sunil Chada, Ph.D., Head of Development Ruga Corporation

Richa Chandra, M.D., MBA Global Program Medical Director Novartis

Joseph Chapman, M.A., HHS/ASPR/BARDA

Arnab Chatterjee, Ph.D., Director Medicinal Chemistry Calibr

A Ray Chaudhuri, Ph.D., Amyris Inc.

William Cheliak, Ph.D., VP Business Development Chelation Partners Inc

Lillian Chiang, Ph.D., CEO Forge Life Science LLC

David Cho, Ph.D., FDA

Kalidip Choudhury, Ph.D., Xbiotech

Claudia Christian, M.S., Vice President Global Operations Clinicalrm

George Christopher, M.D., JPM‐Medical Countermeasure Systems

Vittoria Cioce, Ph.D., HHS/ASPR/BARDA

Denise Ciotti, , __ VP Business Development Dlh Corporation

Adam Clark, Ph.D., HHS/ASPR/BARDA

Matthew Clark, Ph.D., LTC Chemical Defense Pharmaceuticals

John Clerici, JD Principal Tiber Creek Partners LLC

Ronald Cobb, Ph.D., CSO Nanotherapeutics

J. Robert Coleman, Ph.D., Chief Operating Officer Codagenix Inc.

Chad Colfer, B.S., Regulatory Operations SME HHS/ASPR/BARDA

Allen Comer, Ph.D., Director of Research and Development Stratatech Corporation

Stephen Conafay , J.D. Principal The Conafay Group

Thomas Connolly, B.A., Business Development Medical Science And Computing

Michael Connolly, Ph.D., Int.

Wendell Conyers, B.S., HHS/ASPR/AMCG

David Cooper, Ph.D., Laboraroty Director Sri International

Michael Corle, , Military SGT First Line Technology

Sally Cors, MBA Meridian Medical Technologies

Donna Cotton, B.A., Sr. Government Contracts Specialist Meridian Medical Technologies

Manon Cox, Ph.D., MBA President and CEO Protein Sciences Corp

Mark Craven, Ph.D., HHS/ASPR/BARDA

David Cullin, Ph.D., V.P. Research and Development Flir Systems

3

  

  

           

       

    

          

          

    

              

       

          

                     

            

          

             

    

         

       

        

                  

                               

 

           

       

              

            

                

    

        

       

  

        

       

                 

               

       

  

                

               

        

 

         

               

              

                  

       

             

    

  

              

              

       

    

                   

             

          

  

Christopher da Costa, M.D., Synthetic Biologics

Jennifer Dabisch, B.S., Dod Jpeo‐Cbd/Mcs‐Diagnostics

Nancy Daborowski, MSN Senior Director PPD

Shawn Dalle Lucca, M.S., JD Dl Resolut

Bruce D'Arienzo, B.S., Director Federal Contracts Sanofi Pasteur

Gregory Davenport, Ph.D., Vice President The Conafay Group

Carla D'Aveta, B.A., CCRP Senior Project Manager Rho Federal Systems Division Inc

Gloria David, Ph.D., Principal Research Scientist Rho Federal Systems Division Inc

Randall Deck, B.S., Global Director Pandemic Contracts Management Seqirus Inc.

Shana Deitch, M.P.H., GOA

Chiranjit Deka, Ph.D., CEO Indexus Biomedical LLC

YVETTE DELPH, MBBS DA DR. Social & Scientific Systems Inc

Dwight Deneal, B.S., Small Business Officer U.S. Department Of Health And Human Services Office Of Small Business

Sudhir Devalia, M.A., Senior Director PPD

Nicki deVore, Ph.D., FDA/CDER Lisa Diamond, none CEO Pinpoint Science LLC

Andrea DiCarlo‐Cohen, Ph.D., Program Officer NIH/NIAID

Mark Dillon, B.S., President Bio Med Sciences Inc.

Giovannin DiPietro,MBA, HHS Client Relations Executvie Optum

Gary Disbrow, Ph.D., HHS/ASPR/BARDA

Armen Donabedian, Ph.D., HHS/ASPR/BARDA

Raymond Donnelly, Ph.D., Senior Investigator FDA

John Donnelly, Ph.D., President Global Healing

Kelley Doran, , JD Partner Pepper Hamilton Llp

Thomas Dreier, Ph.D., HHS/ASPR/BARDA

Kenneth Dretchen, Ph.D., Chief Science Officer Mesa Science Associates

Pamela Duchars, B.S., Director External Development Emergent Biosolutions

Matthew Duchars, Ph.D., Emergent

Martin Duenas, M.S., Director Leidos

Melissa Dupree, Ph.D., Managing Director Mcallister & Quinn

Jennifer Eddins, B.A., Relationship Management Coordinator Emergent Biosolutions

Carolyn Edelstein, MPA Director of External & Regulatory Affairs Openbiome

Paul Eder, Ph.D., HHS/ASPR/BARDA

Tom Edlind, Ph.D., Founder Microbitype LLC

Alease Edmonds, HHS/ASPR/BARDA

Michael Egan, Ph.D., Director of Immunology Profectus Biosciences

Michael Eichberg, Ph.D., Director Strategic Alliances Merck

Leo Einck, Ph.D., Consultant Epivax

Kelly Ekroos, M.S., Global Emergency Care Markets Lead Meridian Medical Technologies

John Eldridge, Ph.D., Profectus Biosciences Inc

Schuyler Eldridge, M.S., Deputy Director HHS/ASPR/AMCG

4

  

  

                

              

        

       

         

          

             

  

            

                  

          

  

       

            

                   

                 

           

            

    

              

        

       

             

    

  

           

        

            

            

           

    

           

       

    

             

 

                

          

         

        

           

  

            

       

  

                

       

            

    

             

        

  

             

          

      

  

Evelyn Ellis‐Grosse, Ph.D., Chief Scientific Officer Zavante Therapeutics Inc

Kate Eltzroth, M.S., Martin Blanck And Associates

Jessica Ely, Contractin ACC‐APG‐NCD

James Embree, M.S., HHS/ASPR/BARDA

Bill Enright, M.S., Altimmune Inc.

John Esker, Ph.D., HHS/ASPR/BARDA

Eric Espeland, Ph.D., Branch Chief Vaccines HHS/ASPR/BARDA

Tyler Evans, J.D. Covington & Burling Llp

Jason Ezzelle, B.S., MT (ASCP) Senior Director Icon Clinical Research

Tremel Faison, M.S., Regulatory Specialist HHS/ASPR/BARDA

Bernard Fanget, Ph.D., Abivax

Gerry Farrell, Ph.D., COO Fujifilm Diosynth Biotechnologies Texas

Ali Fattom, Ph.D., Sr. VP oif Vaccine R&D Nanobio Corp

Ezra Felker, MBA Chief Business Officer Venatorx Pharmaceuticals

Gillian Fenton, J.D. Senior Counsel GSK Vaccines

Joni Fernbaugh, M.S., Federal Health Business Development Director Noblis

Christine Ferragine, Ph.D., Manager of Government Affairs Senior Scientist Biologics Resources LLC

Joe Figlio, M.S., HHS/ASPR/BARDA

Alan Fine, Ph.D., President Alentic Microscience

Kwame Fosu, HHS/ASPR/AMCG

Francois Franceschi, Ph.D., Program Officer NIH/NIAID

Eric Francois, M.A., Scynexis

Debra Fraser‐Howze, M.A., Orasure Technologies Inc.

Wendy Freeman, B.S., Pinnacle Management Systems

Kathy Freeman, BSN Vice President Business Development Clinicalrm

Douglas Freitag, M.S., Bayside Materials Technology

Philomena Fritz, M.S., Philips Research

Phyllis Frosst, Ph.D., Director Public Policy Seqirus

Gary Fujii, Ph.D., President and CEO Molecular Express Inc.

Joan Fusco, Ph.D., Newlink Genetics/BPS

Alexis Gabard, M.S. Keranetics LLC

Sonia gales, M.S. NIH/NIAID

Efrain Garcia, Ph.D. Health Scientist/Project Officer HHS/ASPR/BARDA

Andrew Geltman, J.D. Merck & Co. Inc.

Joseph Gerstner, Ph.D., HHS/ASPR/BARDA

Gautam Ghatnekar, Ph.D., President and CEO Firststring Research Inc.

Chandrabali Ghose‐Paul, Ph.D., Founder Bioharmony Therapeutics

John Gill, M.S., Pharmathene Inc.

Kevin Gilligan, Ph.D., Sr. Scientific Advisor Clinicalrm

Julia Gin, , CHES HHS/OS/ASPR/OPP

Lallan Giri, Ph.D., CEO Biologics Resources LLC

Sean Givens, B.S., COO Miodx

Geoffrey Glauser, B.S., HHS/ASPR/BARDA

5

  

  

        

      

  

         

       

      

             

       

    

       

  

           

      

              

            

          

              

               

              

       

   

             

                 

              

       

        

             

             

       

  

           

       

        

           

              

       

    

           

            

    

           

 

         

  

                

       

      

           

        

          

        

            

            

                      

       

  

             

               

                

          

Brad Goble, , MBA Medicago

Alan Goldberg, MBA HHS/ASPR/BARDA

Andrew Goldsmith, M.A., Pathsensors Inc.

Frank Gottron, Ph.D., Congressional Research Service

Robert Gougelet, M.D., Medical Engineering Partners LLC

Marcy Grace, Ph.D., Interdisciplinary Scientist HHS/ASPR/BARDA

Kimberly Grantham, M.S., HHS/ASPR/BARDA

Gretchen Green, B.A., Government Business Manager SNBL USA Ltd.

JOHN GREGG, , MBA CEO Balinbac Therapeutics Inc.

Sean Gregory, Ph.D., Battelle Memorial Institute

Trudy Grossman, Ph.D., Avacyn Pharmaceuticals

Denis Guenette, B.S., Senior Scientist Techulon Inc.

Nicholas Guerin, B.A., Program Analyst Integrity Management Consulting

William Guilford, Ph.D., President Gemmus Pharma Inc

Tina Guina, Ph.D., NIH/NIAID

Farshad Guirahoo, Ph.D., Senior VP R&D Geovax

Mounica Gummadi, B.A., Business Operations Associate Prevail Infoworks Inc

Marc Gurwith, M.D., Chief Medical Officer Paxvax

Benjamin Guthrie, M.S., Vice President Venesco LLC

Gabe Gutierrez, Ph.D., Senior Program Manager Leidos

Nadean Gutierrez, B.S., Scientist Southwest Research Institute

Quintin Hackshaw, B.S., HHS/ASPR/AMCG

Jonathan Haines, M.S., Director Sanofi Pasteur

Veronica Hall, Ph.D., Sr Director Emergent Biosolutions

Thomas Handel, B.S., General Manager Pfizer

Sheila Harley, M.A., Harley Business Group LLC

Maggie Harris, B.S., ESC Inc.

Raymond Harris, Ph.D., Program Officer NIH/NIAID

Darnisha Harrison, B.S., President & CEO Ennaid Therapeutics

Shelley Hartman, B.A., CEOAegle Therapeutics Corp.

Richard Hatchett, M.D., Director (acting) HHS/ASPR/BARDA

Adam Havey, B.S., EVP & President Biodefense Division Emergent

Andrew Hawkins, B.S., East End Group

Diane Heck, Ph.D., Professor and Chair New York Medical College

Christins Hedberg, MBA BS Independent Consultant

Astrid Helgeland, M.A., CEPI

David Helton, B.S., Chief Scientific Officer Repurposed Therapeutics Inc.

Ian Henderson, Ph.D., Emergent Biosolutions Inc.

D. Gray Heppner, M.D., Chief Medical Officer Newlink Genetics

Kristen Herring, Ph.D., HHS/ASPR/BARDA

Alexander Heyl, MBA Chief Executive Officer Heyltex Corporation

Terence Hill, Ph.D., Senior Microbiologist Applied Research Associates

Steve Hinrichs, M.D., Univ Of Nebraska Medical Center

Robert Hnatuk, Thermo Fisher Scientific

6

  

  

              

            

       

      

         

            

       

      

             

    

                 

             

  

                

            

  

        

       

         

 

                

        

               

          

            

       

  

                 

            

          

  

             

            

                   

          

               

            

 

           

                    

            

                      

           

                 

       

          

            

            

        

      

                  

            

 

              

 

Sam Ho, Ph.D., Project Manager Molecular Express Inc.

Russ Holbert, B.S., Vice President BD

Wendy Holman, B.S., CEO Ridgeback Biotherapeutics

Mary Homer, Ph.D., Chief HHS/ASPR/BARDA

Michael Hornsey, Ph.D., University Of Surrey

Christopher Houchens, Ph.D., Health Scientist HHS/ASPR/BARDA

Robert House, Ph.D., Senior VP Government Contracts Nanotherapeutics Inc.

Susan Houser, B.S., MBA PMP Program Manager Battelle Memorial Institute

Tom Hu, Ph.D., MBA DABMP Project Officer HHS/ASPR/BARDA

Dora Hughes, M.D., Senior Policy Advisor Sidley Austin LLP

Rosemary Humes, M.S., Diagnostics Science Advisor HHS/ASPR/BARDA

Chuong Huynh, M.S., HHS/ASPR/BARDA

Pennie Hylton, Ph.D., RQA Quality Branch Chief HHS/ASPR/BARDA

LTC Michael Ingram, B.S., Joint Product Manager JPDM MCS/BDTX

Lloyd Ison, M.S., Biomedical Sr. Dir. Device Engineering & Project Mgmt Cerus Corporation

Joseph Italiano, Ph.D., Platelet Biogenesis

Sterling Ivison, B.S., Smart Consulting Group

Narayan Iyer, Ph.D., HHS/ASPR/BARDA

Joany Jackman, Ph.D., Jhu Center For Poct For Std

Scott Jackson, Ph.D., Group Leader NIST

Alan Jackson, M.S., Program Analyst HHS/ASPR/BARDA

James Janicki, B.S., CEO 3I Diagnostics Inc.

Thale Jarvis, Ph.D., CSO Crestone Inc

William Jay Treat, Ph.D., Director National Center For Therapeutics Manufacturing

Linda Jenckes, B.A., Linda Jenckes

Peter Jenkins, M.D., MBBS FRAC Aus Bio Limited

George JIANG, M.D., Defense Health Agency

Jin‐an Jiao, Ph.D., Sab Biotherapeutics Inc.

Leslie Johnson, Ph.D., Program & Alliance Management Moderna Therapeutics Valera Venture

Randall Johnson, B.S., Director Contract Administration Cook Pharmica LLC

Alan Johnson, Ph.D., Director of Chemistry Hawaii Biotech Inc.

Bretrand Jones, MIS President Supreme Solutions

Evan Jones, B.A., MBA Chairman and CEO Opgen Inc.

Matthew Jones, B.S., Chief Commercial Officer Dyadic International Inc.

Mary Just, B.A., Senior Analyst Avascent

Matthew Kalnik, Ph.D., Antidote Therapeutics Inc.

Amit Kapoor, M.S., President First Line Technology

Maggie Keane, B.S., Director Medical Affairs Merck & Co. Inc.

George Keane, M.A., Contracting Officer HHS/ASPR/AMCG

Eric Keller, JD Chief Business Officer Sipnose Ltd.

7

  

  

              

                

    

              

       

      

             

           

            

     

      

              

    

            

                

                 

       

              

             

 

               

          

            

            

           

       

  

             

       

        

              

          

            

             

      

       

         

                   

             

          

             

            

              

  

          

          

  

           

  

           

            

            

                

                     

               

 

Helmut Kessmann, Ph.D., Head Business Development Polyphor Ltd

Joan Keutzer, Ph.D., Vice President & Head Intergrated Solutions Sanofi Genzyme

Nicole Kilgore, M.S., Deputy JPM MCS‐JVAP MCS‐JVAP

Mee Kim, Ph.D., Pharmacologist Durect Corporation

Kenneth Kim, M.D., CEO Clinical Research Organization

Mark Kim, MBA Senior Auditor HHS/ASPR/AMCG

Kelly Klein, B.S., Program Mgr HHS/ASPR/BARDA

Antoinette Knight, Program Analyst HHS/ASPR/BARDA

Bryan Knysh, M.S., MBA Director of External Partnerships Click Diagnostics

Hon‐Sum Ko, M.D., Medical Officer FDA

Paul Ko Ferrigno, Ph.D., Avacta Life Sciences Ltd

Lynnet Koh , MBA Chairman & CEO Targazyme Inc.

Kenichiro Kondo, Ph.D., Senior Project Manager Meiji Seika Pharma Co. Ltd.

George Korch, Ph.D., Senior Science Advisor HHS/ASPR

Mark Kortepeter, M.D., Univ. Of Nebraska Medical Center

Akhila Kosaraju, M.D., SIGA Technologies

Pooja Kothari, M.P.H., Pew Charitable Trusts

Gerry Kovacs, Ph.D., Senior Advisor HHS/ASPR/BARDA

Amy Krafft, Ph.D., Program Officer NIH/NIAID

Arthur Kreitenberg, M.D., DimerLLC/Germfalcon

Elliot Kreitenberg, B.S., Dimer LLC (Dba Germfalcon)

Rajesh Krishnamurthy, Ph.D., CTO 3I Diagnostics Inc.

Fredrick Kristensen, M.D., Coalition For Epidemic Preparedness Innovations

Frederic Krohn, M.S., Curevac. Inc

Susanna Kuebler, Senior Analyst U.S. Government Accountability Office

raj kumar, M.D., Medicne an DOCTOR Vitas Pharma

Anna Kushnir, Ph.D., SMI

Maya Kuttan, B.A., JD Scibac

Joseph Labrie, Ph.D., Scientist Medical Countermeasures Systems / Biodefense Therapeutics

Clifton Lacy, M.D., Institute Director Rutgers Institute For Emergency Preparedness And Homeland Security

Sushmita Lahiri, Ph.D., Executive Director Macrolide Pharmaceuticals

Kyle Lane, B.S., Kp Biosciences Incorporation

Judith Laney, Ph.D., Branch Chief Chemical MCMs HHS/ASPR/BARDA

Kelly Lange,J.D. Partner East End Group

Tim Lant, Ph.D., Division Director HHS/ASPR/BARDA

Joseph Larsen, Ph.D., Deputy Director (Acting) HHS/OS/ASPR/BARDA

Jeffrey Laskin, Ph.D., Professor Rutgers University

Peter Latham, M.S., Latham Biopharm Group

Janet Lathey, Ph.D., Program Officer DMID/NIAID/NIH

Sabine A. Lauer, Ph.D., Lauer Research & Consulting

Sau (Larry) Lee, Ph.D., Acting Deputy Director Food And Drug Administration

Mark Lee, Ph.D., Director of Business Development Certara

8

  

  

           

          

        

               

                    

          

                    

         

          

         

          

            

            

        

              

      

           

 

                    

       

      

         

               

    

  

       

            

      

    

        

       

          

           

          

          

       

                     

 

         

        

            

            

                         

               

                   

            

  

              

      

            

              

    

       

        

      

John Lee, Ph.D., Health Scientist HHS/ASPR/BARDA

Elizabeth Leffel, Ph.D., Heyltex Corp.

Brad Leissa, M.D., FDA

Keith LeJeune, Ph.D., SVP Research Allegheny Health Network

Robert Lemon, M.A., MBA Executive Director VxPDC International Aids Vaccine Initiative

Matthew Lesho, Ph.D., Luminex Corporation

Rachel Levinson, M.A., Executive Director National Research Initiatives Arizona State University

Marie Ann Leyko, Ph.D., Sr. Scientist CCS Associates Inc.

Li‐fang Liang, Ph.D., Medivector Inc.

Dave Liebowitz, M.D., Vaxart Inc.

Scott Lillibridge, M.D., Professor of Epidemiology Texas A&M University School Of Public Health

WeiQi Lin, Ph.D., MD Sr. VP R&DDurect Corporation

Leah Lipsich, Ph.D., Regeneron Pharmaceuticals Inc

Geneva Little, B.A., Medical Countermeasure Systems

Carla Little, Ph.D., MCM Program Manager Illinois Department Of Public Health

Samuel Lockhart, M.Div. PresidentHouse Color Screens Inc./HCS

Stig Loefberg, MBA CEO Meabco

Nicolette Louissaint, Ph.D., Director of Programming Healthcare Ready

Linda Luczak, HHS/ASPR/AMCG

Rebekka Lueptow, M.P.H., HHS/ASPR/BARDA

STEVEN LUPERCHIO, Ph.D., Senior Director Clinical Development and Program Management Arsanis Inc.

Nicole Lurie, MD MSPH HHS/OS/ASPR

Kazunori Maebashi, Ph.D., Meiji Seika Pharma Co. Ltd.

Renae Malek, Ph.D., Chief Scientist DOD

Uday Malhan, M.S., Conviso Inc.

Brett Malone, Ph.D., Topgear Bioscience

Robert Malone, M.D., CEO Atheric Pharmaceutical LLC

Jill Malone, Ph.D., VP Atheric Pharmaceutical LLC

William Manel, B.A., MSC LLC

Ava Manokian, B.A., Emmes

Maja Maric, Ph.D., Program Officer NIH/NIAID

Mark Martin, Ph.D., Johnson & Johnson

Larry Martinelli, BS MBA Dir. of Engineering & Commercial Scale Up Materials Modification Inc.

Chris Mason, , Juris Doct VP Contracting/Legal Clinicalrm

James Matthews, Ph.D., Head of US Federal Contracts Sanofi Pasteur

Iva Maxwell, Ph.D., Senior ScientistMeso Scale Diagnostics

Elebeoba May, Ph.D., Associate Professor University Of Houston

Marie Mazur, Pharm.D. VP Global Comm Dev & Policy Seqirus

Bruce McAfee, B.S., Area Director Government Business Development Fisher Bioservices

Dan McCabe, B.A., Medimmune

Jay McCrensky, Ph.D., CEOAdoptive Therapeutics Inc.

9

  

  

         

            

       

  

                  

                

      

        

       

                     

       

      

             

        

            

            

            

          

         

           

           

            

              

      

             

                  

             

       

      

             

     

          

               

     

          

       

           

  

       

           

           

  

           

    

       

      

           

            

                

              

    

         

              

          

                        

        

 

Joe McDonough, Ph.D., Director Swri

Michael McGinnis, M.S., Latham Biopharm Group

Joseph McGowan, M.A., Glaxosmithkline

William McMahon, , M.B.A. Senior Program Analyst/EVM Integrity Management Consulting

John McManus, B.S., President & Chief Executive Officer Aeolus Pharmaceuticals Inc.

Dorothy McMillan, M.S., HHS/ASPR/AMCG

Tasha McMillian, B.S., HHS/ASPR/AMCG

Patti McNamara, M.S., VP Govt and Public Health Services PPD

Michael McNeely, Ph.D., President/CEO Gattaco LLC

Viktor Meineke, M.D., Prof. Dr.Int Scientific Consulting

John Mekalanos, Ph.D., HMS

Dunstana Melo, Ph.D., President Melohill Technology

Valerie Mermall, Ph.D., Protein Sciences Corporation

Jeffrey Meshulam, B.A., Profectus Biosciences Inc.

David Metzgar, Ph.D., Principal Scientist IBIS Biosciences An Abbott Company

Jeremy Middleton, B.S., Elusys Therapeutics Inc.

Jake Miles, M.B.A. Sab Biotherapeutics Inc.

Eugene Millar, Ph.D., Assistant Professor USU

Kristy Miller, M.P.H., Director of Project Delivery PRA Health Sciences

Christina Millin, B.A., Director Proposals & Contracts Rho Federal Systems Division

Tim Min, J.D. Counsel Intron Biotechnology

Kesha Mitchell, MBA MSHR Program Analyst ASPR/BARDA

Thomas Mitchell, M.A., Finch Therapeutics Inc.

Nrusingh Mohapatra, Ph.D., Cheif Scientist Techulon Inc

Daniel Molina, VP Strategic Planning Technical Resources International

Dennis Molnar, B.A., MBA Helperby Therapeutics Usa Inc

Victor Montalvo‐Lugo, Sr. Director Clinical Operations Emergent Biosolutions

Theresa Moody, M.S.,

Lisa Moore, B.S. M.B. Senior DirectorEmergent Biosolutions

Richard Moreno, M.S., HHS/ASPR/BARDA

Michael Mulligan, B.S., Battelle Memorial Institute

Josh Muntner, MBA SVP Business Development Contrafect

Michael Murray, Ph.D., Director Government Business Development Southern Research

Thomas Muster, Ph.D., CSO Vivaldi Biosciences

Thomas Muster, Ph.D., CSO Vivaldi Biosciences

Charlie Mutschler, M.S., Program ManagerPhilips Healthcare

Charles Nau, J.D. Director Federal Affairs Johnson & Johnson

Stephanie Nealis, M.S., Director of Business Development Dovel Technologies

Tanya Nelson, M.S., Operations AnalystEmergent

Yolanda Nesbeth, Ph.D., Director Celdara Medical LLC

Yoichi Niitsu, Ph.D., Daiichi Sankyo

Emmett Noe, M.A., Global Manager Technical & Clinical Support Becton Dickinson And Company

David Noll, Ph.D., Tibercreek

10

  

  

                

               

            

       

          

             

       

  

        

          

            

  

           

                         

          

        

       

  

               

                

      

            

     

                      

    

             

                  

       

  

       

                

          

  

           

              

 

             

          

       

      

         

          

                     

                   

            

            

                        

            

       

         

      

           

 

Bianca Noronha, B.S., Data Manager/Protocol Monitor The Emmes Corporation

Ed Nuzum, DVM PhD Chief Vaccine Dev Section NIH/NIAID

Jose Ochoa, J.D. Idt Biologika Corporation

Thomas O'Connor, Ph.D., US Food And Drug Administration

Michael O'Hara, Ph.D., Sr. Progm. Mgr. HHS/ASPR/BARDA

Isaiah Okyere, M.S., HHS/ASPR/AMCG

David Olive, JD Catalyst Partners

Carol Olson, , MD PhD VP & Theraupeutica Area Head Infectious Diseases PPD

Andrew Omidvar, M.D., VP Philips Healthcare

Katie Overheim, Ph.D., Director of Applied Infectious Disease Research Scientist Lovelace Respiratory Research Institute

Chris Paddon, Ph.D., Amyris Inc.

Laura Paganucci, Ph.D., Westat

Germain Palmer, B.A., HHS/ASPR/BARDA

James Pannucci, Ph.D., Senior Director ‐ Infectious Disease Research Southern Research

Hyeon Park, Ph.D., Director of Product Development & Manufacturing Biologics Resources LLC

Tina Parker, DVM MSPH Program Officer NIH/NIAID

Tawana Parker DHHS

Gerald Parker, Ph.D., DVM Public Health Preparedness And Response Texas A&M University Health Science

Elliot Parks, Ph.D., CEO Hawaii Biotech Inc.

Myra Patchen, Ph.D., PhD Chief Scientific Officer Immuno Research Inc.

Corrina Pavetto, M.S., HHS/ASPR/BARDA

Pamela Payne, MPA HHS/ASPR/BARDA

Aaron Pendola, B.A., Medical Science & Computing LLC

Marietta Percy, Supervisory Management Analyst HHS/ASPR/BARDA

Danielle Peters, M.A., Magnet Strategy Group

Carey Petrie, Ph.D., Project Director The Emmes Corporation

Ly Phan, Ph.D., VP Medicinal Chemistry and Antibacterial Discovery Warp Drive Bio Inc.

Gwendolyn Phillips, B.S., Account Manager ESRI

Dennis Pierro, Ph.D., Director Biomarc

Frank Pietrucha, B.A., Definitive Communications

Aprile Pilon, Ph.D., Executive Vice President & CSO Therabron Therapeutics Inc.

Ronald Pivarnik, M.A., MBA Director of Programs Scientific & Biomedical Microsystems

Artur Plonowski, Ph.D., Jovis Pharma Inc.

Jerry Pommer, M.S., Sab Biotherapeutics Inc.

Ronald Poropatich, M.D., Executive Director Center for Military Medicine Research University Of Pittsburgh

Penny Post, Ph.D., Protein Sciences Corporation

Kristy Pottol, M.S., USAMMDA

Liz Powell, M.P.H., Esq. President G2G Consulting

Daniel Prabakaran, Ph.D., Ascension Biosciences LLC

11

  

  

         

    

            

    

           

       

      

                 

      

        

             

                   

          

                 

            

          

        

  

         

               

       

                 

          

  

          

        

            

        

             

    

       

             

        

       

  

         

 

             

      

    

           

      

       

    

       

              

  

                     

       

        

          

              

            

       

    

       

             

 

Brian Price, Ph.D., Director Biopharmaceutical Development Battelle

Christopher Primiano, J.D. M.B. Senior Vice President Karyopharm Therapeutics

Brian Prue, M.S., Charles River Analytics

Raymond Puerini, M.P.H., Senior Program Analyst Naccho

Daniel Py, Ph.D., Founder & Chairman Medinstill Development LLC

Jingyuan Qian, M.P.P. Senior Research Assistant Duke University

Charley Quinn, MBA Humphreys & Associates Inc.

Anne Radcliff, Ph.D., Director Biological & Medical Sciences Cubrc Inc.

Mark Rampy, Ph.D., Sequella Inc.

Story Randy, M.A., Dir of Logistics DOD Health Affairs

Radha Rangarajan, Ph.D., CEO Vitas Pharma

Robert Raulli, Ph.D., BS MBA HHS/ASPR/BARDA

Dan Read, Ph.D., MRIGlobal

Samuel Reed, M.S., DNA Electronics

Matthew Reed, Ph.D., Senior Scientist Lovelace Respiratory Research Institute

Taylor Reed, M.S., HHS/ASPR/OPP

John Rex, M.D., Chief Strategy Officer CARB‐X Carb‐X

Michele Riggs, B.A., Contract Specialist HHS/ASPR/AMCG

Stephen Riordan, MBA Vice President Westat

Safia Rizvi, Ph.D., Agenus

Safia Rizvi, Ph.D., The Blue Group

S. Kyle Roberts, J.D. HHS/ASPR/AMCG

Scot Roberts, Ph.D., Chief Scientific Officer Altimmune Inc.

Rosemary Roberts, M.D., FDA/CBER

George Robertson, Ph.D., SENIOR TECHNICAL ADVISOR PATH

Elizabeth Robins, Wearth Solutions

Doreen Robinson, Ph.D., Genarraytion

Katina Robinson Wright, B.A., HHS/ASPR/BARDA

Benjamin Roccanova, JD Senior Legal Counsel PSI‐CRO

Michelle Rodrigues, MBA SRI International

Kelley Rogers, Ph.D., Biosciences Program Advisor Nist Material Measurement Laboratory

Paul Roney, Ph.D., Regulatory Specialist HHS/ASPR/BARDA

David Rouse, M.S., Sr. Scientist for Counterterrorism and Emerging Threat Preparedness FDA/CBER

Stefanie Ruck, B.S., Director Business Development Health and Human Services Engility Corporation

Api Rudich, Ph.D., Medivector

Carl Ruggiero, B.S., President of Consulting Lexem Strategy LLC

Wilson Rumbeiha, Ph.D., Professor Iowa State University

Carol Sabourin, Ph.D., Chief Scientist Battelle

Lindsay Sacco, B.A., G2G Consulting

Leonard Sacks, M.D., FDA

Randy Sakowitz, BBA Vice PresidentFirst Line Technology

12

  

  

         

       

  

                 

        

            

               

            

             

               

          

            

            

  

       

         

 

         

                  

        

        

             

  

       

               

            

  

       

            

                 

            

 

           

    

           

 

         

            

              

            

       

  

             

       

             

         

        

   

       

          

       

      

          

              

    

Andres Salazar, M.D., CEO Oncovir

Giovanni Salerno, M.S., Evolva

Rachelle Salomon, Ph.D., Program Officer for Influenza Vaccine R&D NIH/NIAID

Michael Sander, Sastomed Gmbh

Patrick Sanz, Ph.D., Project Officer NIH

Vadim Sapiro, B.S., Chief Information Technology Opgen Inc.

Laura Sappelsa, M.A., Senior Analyst ANSER

Gary Sauer, M.S., Vice President Schafer Corporation

Alexis Sauer‐Budge, Ph.D., Senior Research Scientist Fraunhofer Cmi

Jess Scarbrough, M.S., Director HHS/ASPR/AMCG

Mary Schaheen, Other , Executive Chairwoman Prevail Infoworks Inc.

Paul Schaudies, Ph.D., Genarraytion

Manfred Scheske, Infirst+ Healthcare

Helen Schiltz, Ph.D., NIH/NIAID

Brian Schimmoller, M.S., Vice President Signature Science LLC

Ed Schmidt, Ph.D., Project Manager Unisec Consortium

Jennifer Schneider, Ph.D., Principal Tiber Creek Partners LLC

Monika Schneider, Ph.D., Duke‐Margolis Center For Health Policy

Scott Schneiderman, M.A., Aveshka

Ronda Schreiber, Ph.D., Associate Director Product Development Organogenesis

Jo Schweinle, M.D., Sr. Medical Officer HHS/ASPR/BARDA

Kimberly Sciarretta, Ph.D., HHS/ASPR/BARDA

Brenton Scott, Ph.D., President Pulmotect Inc.

Matt Scullion, B.S., VP Sales and Marketing Biofire Defense

Jonathan Seals, Ph.D., Division Director HHS/ASPR/BARDA

Dagmar Sebastian, Ph.D., Complex Programs Lead Pfizer Inc

Kelly Seyed, Ph.D., Mcallister & Quinn

Joseph Sgherza, B.S., President Clinicalrm

Maureen Shanks, Ph.D., Emergent Biosolutions Inc.

Wendy Shelton, DVM MPH Principal Colorado State University

BONNIE SHEN, M.S., Project Officer HHS/ASPR/BARDA

Oleg Shinkazh, B.S., Chromatan

Carolyn Shore, Ph.D., The Pew Charitable Trusts

Rajesh Shukla, Ph.D., Vice PresidentMotif Biosciences

John Shumway, B.A., I2biomed

G. Fertram Sigurjonsson, M.S., Kerecis

Ivan Silva, Ph.D., HHS/ASPR/BARDA

David Simon, Ph.D., HHS/ASPR/BARDA

Jeanette Simpson, Ph.D., Pathsensors Inc.

Tanima Sinha, M.S.P.H., Lead Interdisciplinary Scientist HHS/ASPR/BARDA

Ed Sistrunk, M.S., MRI Global

Paul Skalny, M.S., Partner VP for Business Development Visca LLC

13

  

  

           

    

            

           

           

            

       

          

          

          

  

                

       

                   

  

             

       

  

       

         

       

        

           

              

            

    

             

          

        

           

              

            

                   

        

            

                   

 

                 

                 

            

       

    

        

       

    

       

              

                

          

                

       

      

       

             

                

    

Mario Skiadopoulos, Ph.D., Sr. Director Non‐Clinical Development Emergent Biosolutions

Laura Smart, M.A., Tiber Creek Partners

Denise Smart, JD Smart Consulting Group

Julian Smisek, MBA Finch Therapeutics Inc.

Mark Smith, Ph.D., Finch Therapeutics Inc.

Doris Snow, Ph.D., Sr. Director Regulatory Affairs Nanotherapeutics Inc.

Barbara Solow, Ph.D., Emergent Biosolutions

Kirsten Sorensen, B.S., Program Analyst HHS/ASPR/COO

Joshua Speidel, Ph.D., Managing Director Latham Biopharm Group Inc

Richard Spero, Ph.D., CEO Redbud Labs

Beth Spinelli, M.S., Drug Development Program Officer NIH/NIAID

Stephen Sproul, B.S., Director of Sales Micronics

Robert Stahl, Ph.D., HHS/ASPR/BARDA

Timothy Stephens, M.A., Celero

Mark Stidham, Ph.D., DirectorResolute Therapeutics

Dan Stinchcomb, Ph.D., Executive Chair Flugen Inc.

Robin Stombler, B.S., Auburn Health Strategies

Heather Stone, M.P.H., Public Health Analyst FDA

Katy Strei, M.S., SVP Human Resources Emergent Biosolutions

Andrew Strong, J.D. Partner Pillsbury Winthrop Shaw Pittman

Ray Styons, B.A., Business Development Meso Scale Diagnostics LLC

Eddie Sullivan, Ph.D., Sab Biotherapeutics Inc.

Audrey Sykes, M.S., Director of Business Development IDT Biologika Corporation

Ray Tabibiazar, M.D., President & CEO Ruga Corporation

Alan Taggart, M.S., Dalya Pattners

Marco Taglietti, M.D., Scynexis

Jim Talton, Ph.D., Alchem Laboratories Corp

John Tamerius, Ph.D., SVP Strategic and External Affairs Quidel Corporation

Richard Tamfu, Ph.D., MBA Director Global Marketing Alpha Diagnostic International

Sharon Tamir, B.S., Associate Director Product Leader Karyopharm Therapeutics

Marc Taraban, Ph.D., University Of Maryland

Sybil Tasker, M.D., Altimmune Inc.

Kimberly Taylor, Ph.D., NIH/NIAID

Marva Taylor, M.S., Biologist/Project Officer HHS/ASPR/BARDA

Sheila Taylor, A.A., HHS/ASPR/AMCG

Sara Terpening, M.S., Deputy CSO Nanotherapeutics Inc

Mary Beth Thomas, Ph.D., Vice President Centers of Innovation Program North Carolina Biotechnology Ctr

Karla Thrall, Ph.D., ARS Program Director SNLB USA

Jeannette Tighe, M.S., VP Business Development Continuum

Nancy Timm, A.A., VP Finance and Business Ops Rebiotix Inc

Ali Tinazli, Ph.D., Global Head of Healthcare Strategy HP Inc.

14

  

  

             

    

                      

        

          

              

             

              

            

             

       

     

           

    

           

        

       

  

               

                        

            

  

             

                 

                 

         

          

              

      

        

         

       

      

  

          

       

   

                 

      

      

      

              

       

   

                    

            

          

         

        

            

       

    

       

        

      

              

                 

Krishna Tobon, Ph.D., Senior Scientist Grants Coordinator Cytosorbents Medical

Ronald Tompkins, M.D., Sc.D. Sumner M. Redstone Prof of Surgery Massachusetts General Hospital

Lauren Trabert, M.S., Aveshka

Silvija Tresnjak‐Smith, B.A., Regulatory Specialist HHS/ASPR/BARDA

Jose Trevejo, M.D., PhD VP Development Visterra

Shane Trexler, MBA Medical Engineering Partners LLC

Mark Trexler, MBA COO Medical Engineering Partners

John Troyer, Ph.D., VP Product Development Pharmathene

Vu Truong, Ph.D., CEO Aridis Pharma

Chia‐Wei Tsai, Ph.D., Chief HHS/ASPR/BARDA

Larry Tsai, M.D., VP Clinical Development Tetraphase Pharmaceuticals

Brian Tse, Ph.D., Health Scientist HHS/ASPR/BARDA

Kenneth Tucker, Ph.D., Leidos

Danielle Turley, Ph.D., HHS/ASPR/BARDA

Dr Robert tuttle, Ph.D., Boston Biotech Consultants LLC

Patrick Twomey, M.D., Chief Clinical Trial Center Walter Reed Army Institute Of Research

Adrian Urias, M.S., Medical Devices SME HHS/ASPR/BARDA

Robert Valdes, M.A., MBA INDUSTRY CONSULTANT Alliancebio LLC

Livio Valenti, M.A., VP of Strategy Vaxess Technologies Inc.

Don Van Dyke, B.A., Chief Operating Officer Cloud Pharmaceuticals

Eric Van Gieson, Ph.D., University Of Nebraska/National Strategic Research Institute

Dr. Jayanand Vasudevan, Ph.D., Senior Scientist MCS/BDTX

Kodumudi Venkateswaran, Ph.D., CEO Omni Array Biotechnology

Richard Vickers, Ph.D., Summit Plc

Warren Villagomez, A.A., PHEP/HPP/ELC Director Commonwealth Healthcare Corporation

Beryl Voigt, B.S., Interdisciplinary Scientist HHS/ASPR/BARDA

Frank Volvovitz, B.A., Biomedisyn Corporation

Phi Vu, M.S. J.D. Director Diagnostics and Personalized Medicine Policy Bio (Biotechnology Innovation Organization)

Melissa Wagner, MBA Sr. Director Hvivo

Meytal Waiss, M.S., Director Business Development Freemind Group

Robert Walker, M.D., HHS/ASPR/BARDA

Terry Walker Ph.D., Ph.D., Senior VP Research & Development Opgen Inc.

Rodney Wallace, B.S., Division Director HHS/ASPR/BARDA

James Wangelin, M.S., MBA RAC HHS/ASPR/BARDA

Lucy Ward, DVM PhD Senior ScientistMedical Countermeasures Systems

Tom Warf, B.S., Division Director HHS/ASPR/BARDA

Paige Waterman, M.D., US ARMY

Michael Wathen, Ph.D., HHS/ASPR/BARDA

Paul Waymack, M.D., ScD Firststring Research Inc.

Kathleen Weber, MBA SVP GM Orasure Technologies Inc.

Milton Werner, Ph.D., President & CEO Inhibikase Therapeutics Inc.

15

  

  

      

        

      

               

         

       

  

             

          

             

                    

                 

       

  

         

              

        

  

                       

          

       

      

             

            

             

          

       

      

         

       

      

           

            

Kim Westmoreland, MBA Keranetics

David White, B.S., MBA Consultant Planet Innovation

William Wick, MBA Chief Operating Officer Vivaldi Biosciences Inc.

Harvey Wilgus, Ph.D., JPEO

Cindy Wilkins, B.A., HHS/ASPR/AMCG

Martin Wirtz, M.D., Vice President Wound Care Therapies and Strategic Programs Mallinckrodt Pharmaceuticals

David Wise, MALD CEO Pharos Biologicals LLC

Richard Wisniewski, MBA Director HHS Egg Supply Contract Sanofi Pasteur Inc.

Laura Wolf, Ph.D., Critical Infrastructure Protection Branch Chief HHS/ASPR/BARDA

Daniel Wolfe, Ph.D., HHS/ASPR/BARDA

Janet Woodcock, M.D., Director HHS/FDA/CDER

Hideki Yamamoto, Ph.D., Daiichi Sankyo Co. Ltd.

Bai Yeh , MBA HHS/ASPR/BARDA

Michele Yelmene, B.S., VP Clinical Development Regulatory Affairs Quality Assurance Hawaii Biotech Inc.

Debra Yeskey, PharmD Division Director HHS/ASPR/BARDA

Dave Yeung, Ph.D., HHS/NIH

Wayne Young, M.Ed. HHS/ASPR/BARDA

Thor Young, B.S., Program Analyst HHS/ASPR/BARDA

Anne Yu, M.S., Deputy Director HHS

Vidadi Yusibov, Ph.D., Executive Director Fraunhofer Usa

Michelle Zaharik, Ph.D., Biolytical Laboratories

Mitchell Zakin, Ph.D., CTO Clear Scientific

Daina Zeng, Ph.D., Agile Sciences

Zachary Zimmerman, Ph.D., CEO Forge Therapeutics

Alexander Zukiwski, M.D., CEO Arno Therapeutics

John Zuluaga, M.A., COL Sanofi Pasteur

16